Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
Immunostimulatory gene therapy has been developed during the past twenty years. The aim of immunostimulatory gene therapy is to tilt the suppressive tumor microenvironment to promote anti-tumor immunity. Hence, like a Trojan horse, the gene vehicle can carry warriors and weapons into enemy territory...
Main Author: | Angelica Loskog |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/7/11/2899 |
Similar Items
-
Oncolytic viruses for cancer immunotherapy
by: Otto Hemminki, et al.
Published: (2020-06-01) -
Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
by: Mubalake Abudoureyimu, et al.
Published: (2019-11-01) -
Corrigendum: Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
by: Mubalake Abudoureyimu, et al.
Published: (2020-05-01) -
Perspectives on immunotherapy via oncolytic viruses
by: Alberto Reale, et al.
Published: (2019-02-01) -
Oncolytic viruses armed with immunostimulatory genes for cancer treatment
by: Šilanskas, Mantas
Published: (2018)